Tag: Acandis
Recent addition to European flow diverter market performs well in multicentre...
A recent addition to Europe’s flow diversion market—the Derivo 2 embolisation device (DED2; Acandis)—has demonstrated promise in a small-scale, multicentre study, providing a safe...
APERIO hybrid thrombectomy device receives CE mark approval
Acandis GmbH announces that it has received European CE mark approval for its APERIO hybrid thrombectomy device. APERIO is intended for restoration of the...
Acandis receives European CE mark approval for its ACCERO stent
Acandis has announced that it has received European CE mark approval for its ACCERO stent, which is now available for sale in Europe. The...
Multicentre study shows Derivo embolisation device to be safe and effective...
Endovascular treatment of unruptured intracranial aneurysms with the Derivo (Acandis) embolisation device is associated with high procedural safety and adequate occlusion rates. All procedures...
Acclino stents feasible in complex bifurcation aneurysms at mid-term follow-up
A new study has found stent-assisted endovascular techniques with Acclino stents (Acandis) are a feasible treatment for complex intracranial aneurysms. Reporting in the Journal...
